Clinical research studies offer a unique way to gain access to experimental medications intended to treat symptoms of Schizophrenia

Posted in: Clinical Trials

Schizophrenia can be a highly debilitating disorder that can impact significantly how people with this disorder think and deal with life’s everyday challenges.  While there are currently multiple drugs that physicians use to treat this disorder, effectiveness of a drug can often times be less than entirely satisfactory or the drug may posses one or more side effects that the user finds troubling or outright unacceptable.  This last point is particularly important as it can significantly undermine compliance that, in turn, can significantly undermine the management of the individual’s symptomatology.

SPRI is a research center that is involved in the conduct of a number of clinical studies targeting psychiatric disorders, including Schizophrenia Research Studies New York City.  To learn more about what’s involved in participating in one of their clinical research studies, contact their site.

There are no comments published yet.

Leave a Comment

Change this in Theme Options
Change this in Theme Options